ATS

Stanford Researchers Find Brain Pathway of Depression in Rats

STANFORD, Calif.--(BUSINESS WIRE)--Jul 5, 2007 - Scientists' huntfor the cause of depression has implicated so many suspects andfound so many treatments with different mechanisms that thecondition remains an enigma. Now researchers at the StanfordUniversity School of Medicine have identified one unifyingprinciple that could explain how a range of causes and treatmentsfor depression converge...

Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failure

MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 19, 2007 - GeronCorporation (Nasdaq: GERN) today reported that research documentingthe scalable production, survival following engraftment andpositive impact on cardiac function in infarcted rats was presentedtoday for GRNCM1, the company's human embryonic stem cell(hESC)-based therapeutic for heart failure, at the InternationalSociety for Stem Cell...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-termmaintenance treatment of COPD bronchoconstriction; data demonstratefirst nebulized formoterol fumarate provides improved lung functioncomparable to dry powder formoterol, enhanced patient quality oflife, and positive safety profile -- NAPA, CA (May 20, 2007) – Data presented at theInternational Conference of the American Th...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenancetreatment of COPD bronchoconstriction; data demonstrate firstnebulized formoterol fumarate provides improved lung functioncomparable to dry powder formoterol, enhanced patient quality oflife, and positive safety profile -- NAPA, Calif., May 20, 2007 /PRNewswire/ -- Data presented at theInternational Conference of the America...

Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007

-- Data from Phase III pivotal trial demonstrate safety andefficacy of first FDA-approved nebulized formoterol fumarate forpatients with moderate to severe COPD -- NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, L.P. announcedthat two clinical data presentations will be given at theInternational Conference of the American Thoracic Society (ATS) onSunday, May 20, at the Moscone Center in S...

Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats

First Scientific Presentation for Pristiq Occurs at the 55th AnnualClinical Meeting of the American College of Obstetricians andGynecologists COLLEGEVILLE, Pa., May 09, 2007 /PRNewswire-FirstCall/ -- WyethPharmaceuticals, a division of Wyeth , presented results from thefirst Phase 3 studies evaluating Pristiq(TM) (desvenlafaxine) forthe treatment of moderate-to-severe vasomotor symptoms (...

Newest Adult Stem Therapy Treats Diabetes

Leaves Individuals With Juvenile Diabetes Insulin-Free WASHINGTON, April 10, 2007 /PRNewswire-USNewswire/ -- In yetanother advance in adult stem cell therapy, the Journal of theAmerican Medical Association (JAMA) today released a study in which14 of 15 Juvenile Diabetes patients demonstrated significantimprovement as a result of an adult stem cell treatment. Accordingto U.S. Rep. Dave Wel...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...